BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32196573)

  • 1. Down-regulation of MIAT suppresses osteosarcoma progression by acting as a ceRNA for miR-141-3p to regulate SIX1-mediated PI3K/AKT pathway.
    Ji Q; Zhu J; Fang CL; Jin H; Zhan DP; Huang J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2218-2228. PubMed ID: 32196573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA myocardial infarction associated transcript promotes the development of thoracic aortic by targeting microRNA-145 via the PI3K/Akt signaling pathway.
    Chen S; Chen H; Yu C; Lu R; Song T; Wang X; Tang W; Gao Y
    J Cell Biochem; 2019 Sep; 120(9):14405-14413. PubMed ID: 30989723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
    Zhang C; Xie L; Liang H; Cui Y
    IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial Infarction-associated Transcript Knockdown Inhibits Cell Proliferation, Migration, and Invasion Through miR-490-3p/Intercellular Adhesion Molecule 1 Axis in Oxidized Low-density Lipoprotein-induced Vascular Smooth Muscle Cells.
    Ma H; Zheng L; Qin H; Wang W
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):617-626. PubMed ID: 33165137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a.
    Wang Y; Kong D
    Cell Physiol Biochem; 2018; 45(2):844-855. PubMed ID: 29414815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
    Wu W; Wang L; Li S
    Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.
    Qi S; Xu L; Han Y; Chen H; Cheng A
    Cell Cycle; 2022 Sep; 21(18):1980-1995. PubMed ID: 35575588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA_103801 accelerates proliferation of osteosarcoma cells by sponging miR-338-3p and regulating HIF-1/Rap1/PI3K-Akt pathway.
    Li ZQ; Wang Z; Zhang Y; Lu C; Ding QL; Ren R; Cheng BB; Lou LX
    J Biol Regul Homeost Agents; 2021; 35(3):1021-1028. PubMed ID: 34157832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
    Guo X; Liu Y; Zheng X; Han Y; Cheng J
    Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Long Noncoding RNA Myocardial Infarction Associated Transcript Suppresses Cell Proliferation, Migration, Invasion, and Glycolysis by Regulation of miR-488-3p/IGF1R Pathway in Colorectal Cancer.
    Liu Y; Peng H; Shen Y; Da R; Tian A; Guo X
    Cancer Biother Radiopharm; 2022 Dec; 37(10):927-938. PubMed ID: 33085926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.